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The G protein-coupled receptors (GPCRs), one of the 
largest protein families, are essential components of 
the most commonly used signal-transduction systems in 
cells. These receptors, often using common pathways, 
may cooperate in the regulation of signal transmission 
to the cell nucleus. Recent scientific interests increas-
ingly focus on the cooperation between these receptors, 
particularly in a context of their oligomerization, e.g. the 
formation of dimers that are able to change characteris-
tic signaling of each receptor. Numerous studies on kinin 
and dopamine receptors which belong to this family of 
receptors have shown new facts demonstrating their 
direct interactions with other GPCRs. In this review, cur-
rent knowledge on signaling pathways and oligomeriza-
tion of these receptors has been summarized. Owing to 
the fact that kinin and dopamine receptors are widely 
expressed in cell membranes where they act as media-
tors of numerous common physiological processes, the 
information presented here sheds new light on a puta-
tive crosstalk of these receptors and provides more com-
prehensive understanding of possible direct interactions 
that may change their functions. The determination of 
such interactions may be useful for the development of 
new targeted therapeutic strategies against many dis-
orders in which kinin and dopamine receptors are in-
volved.
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INTRODUCTION
Kinin and dopamine receptors belong to the class 
A (Rhodopsin-like) of the G protein-coupled receptor 
superfamily (GPCRs) responsible for signal transduc-
tion in cells. G protein-coupled receptors have a similar 
structure, which includes seven transmembrane domains, 
three intracellular loops, three extracellular loops, and C- 
and N-terminal tails. Agonist binding to GPCR is the key 
for the initiation of signal transduction; hence, the recep-
tor structure plays an important role in the regulation of 
many physiological cellular functions. Disturbances in 
agonist-receptor binding lead to signaling changes that 
can trigger pathological processes. An emerging topic of 
research involves cooperation between GPCRs that may 
be crucial for the regulation of cell functions (Bouvier, 
2001; Ferre et al., 2014). The effectiveness of the agonist 
action on G protein-coupled receptors depends on many 
factors, among which direct interactions between recep-
tor molecules that form homodimers, heterodimers, or 
high-ordered oligomers can be distinguished (Thomsen 
et al., 2005; Milligan, 2009; Tadagaki et al., 2012). Dif-
ferent types of GPCR assembly have been proposed, 
including disulphide bond formation at the N-terminal 
tails, coiled-coil interaction at the C-terminal tails, and 
direct interactions between transmembrane helices (Bou-
vier, 2001). The formation of GPCR oligomers has been 
widely demonstrated using different techniques, e.g., 
co-immunoprecipitation, bioluminescent resonance en-
ergy transfer, fluorescent resonance energy transfer, and 
proximity ligation assay (Thomsen et al., 2005). There 
is increasing evidence that the formation of GPCR di-
mers/oligomers is associated with a selective regulation 
of physiological processes through changes in signaling 
pathways (Milligan, 2009). Additionally, the association 
of the receptors may be helpful during biosynthesis and 
maturation of receptor proteins (Bulenger et al., 2005; 
Dupre & Hebert, 2006).
GPCRs possess intracellular loops and C-terminal tails 
that may bind to several intracellular proteins named 
GPCR-interacting proteins. This group includes hetero-
trimeric G proteins (with the α, β and γ subunits), which 
initiate different signaling pathways, depending on the 
α subunit type (αs, αi, αq, and α12 subtypes). As a con-
sequence, several secondary messengers such as cAMP, 
inositol phosphate, or Ca2+ are generated or, in opposite, 
their production is inhibited. The cellular responses trig-
gered by these messengers include multiple physiological 
processes such as neurotransmission, cellular metabo-
lism, secretion, cellular differentiation, cell growth, and 
immune responses (Agnati et al., 2003). In recent years, 
investigations of the interactions between GPCRs and 
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β-arrestin have been focused not only on processes re-
lated to the cellular trafficking machinery of receptors 
but also on the function of β-arrestin as an adaptor mol-
ecule that can regulate the receptor signaling (Shenoy 
& Lefkowitz, 2011). The mechanism of the interactions 
between β-arrestin and the receptor is biphasic, includ-
ing a first phase of loose binding of β-arrestin to the 
phosphorylated C-terminal tail of GPCR, followed by 
the docking of this protein to the receptor core (Ghosh 
et al., 2015). Hence, interactions with kinases (GRKs) for 
GPCR phosphorylation are also expected. In fact, such 
interactions lead to increased kinase activity (Maurice et 
al., 2011). It has been suggested that one GRK molecule 
can successfully phosphorylate both receptors in an oli-
gomer complex. Moreover, relevant changes in signaling 
of at least one of the receptors that form this heteromul-
timer can take place after assembling the macromolecu-
lar complex on cell membranes. The activation of one 
of the participating receptors by its agonist may allosteri-
cally suppress or promote the activation of the second 
receptor and may induce conformational changes in the 
receptors, leading to the activation of different signaling 
pathways (Smith & Milligan, 2010; Ferre et al., 2014).
Recently, cooperation of both kinin receptors and do-
pamine receptors with other GPCRs, which modulates 
their functions, has been demonstrated. Since these re-
ceptors are ubiquitously expressed in many tissues, direct 
cooperation between them, which may result in the regu-
lation of crucial cellular processes, seems to be possible. 
Therefore, in this review, we present the most recent 
facts related to protein-protein interaction with concomi-
tant signaling changes for these two classes of receptors, 
which, taken together, strongly support the hypothesis of 
effective and functional cooperation between kinin and 
dopamine receptors.
DOPAMINE RECEPTORS – CHARACTERISTICS AND 
SIGNALING
Dopamine, a catecholaminergic neurotransmitter, is an 
important modulator of diverse functions of the central 
nervous system such as locomotion, cognition, emo-
tion, positive reinforcement, food intake, and endocrine 
regulation (Vallone et al., 2000; Beaulieu & Gainetdinov, 
2005; Hisahara & Shimohama, 2011). This compound 
also regulates a variety of functions regarding, among 
others, the cardiovascular system, hormone secretion, 
and the renal and gastrointestinal system (Missale et al., 
1998). Dopamine acts through specific receptors be-
longing to the GPCRs family. Two groups of dopamine 
receptors have been distinguished, both widely distrib-
uted in human tissues. The D1-like family comprises the 
receptor types D1 (D1R) and D5 (D5R) and the D2-
like family contains the receptor types D2, D3, and D4 
(D2R, D3R and D4R, respectively) (Missale et al., 1998; 
Vallone et al., 2000). The classification of dopamine re-
ceptors is based on their ability to stimulate an intracel-
lular cAMP increase (D1-type receptors) or to down-
regulate cAMP production due to adenylate cyclase (AC) 
inhibition (D2-type receptors).
Although dopaminergic receptors possess a similar 
primary amino acid sequence and a common structure, 
their functions depend mainly on G protein activation 
(Fig. 1). Different G proteins can trigger different sign-
aling pathways; however, G protein-independent signal-
ing has also been demonstrated (Beaulieu et al., 2015). 
Figure 1. Signaling of dopamine receptors. 
Dopamine receptors regulate a variety of processes dependent on calcium ions, PKA, and PKC through G proteins or by G protein-inde-
pendent mechanisms. The figure was prepared on the basis of the information contained in articles cited in the text. AC, adenylate cy-
clase; DA, dopamine; DAG, diacylglycerol; GIRK, G protein-gated inwardly rectifying potassium channel; GSK-3, glycogen synthase kinase 
3; IP3, inositol triphosphate; PKA, protein kinase A; PKC, protein kinase C; PLC, phospholipase C.
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In fact, the main signaling pathway that has served to 
differentiate these receptors is related to AC activation, 
which, in turn, regulates the intracellular cAMP level. 
The D1 receptor, through a Gαs/olf protein, activates 
AC with the release of cAMP while an inhibitory effect 
is exerted by D2-like receptors through Gαi/o proteins, 
causing a decrease in the cAMP concentration. cAMP is 
an important secondary messenger that activates protein 
kinase A (PKA) which, in turn, phosphorylates numer-
ous cytosolic and nuclear substrates, regulating diverse 
cellular functions (Sassone-Corsi, 2012). Therefore, a 
crosstalk between dopaminergic receptors and other 
GPCRs on the signaling pathways may be expected 
through the activation of some proteins by this kinase. 
For example, the 32 kDa dopamine- and cAMP-regulat-
ed phosphoprotein is activated by PKA and may func-
tion as a regulator of signal transduction of other 
GPCRs (Greengard, 2001; Beaulieu et al., 2015; Polito 
et al., 2015).
On the other hand, the D1-like receptors can act 
through Gαq promoting cAMP-independent cell signal-
ing. In this case, phospholipase C is directly activated 
by the G protein with subsequent production of inositol 
triphosphate (IP3) and diacylglycerol (DAG). The first 
product leads to increased mobilization of intracellular 
Ca2+, while DAG activates protein kinase C (PKC). A 
similar effect is observed after activation of the D2-
like receptor by dopamine. However, the β/γ subunits 
of the G protein are involved in this signaling. In addi-
tion, intracellular Ca2+ and K+ levels may be modulated 
by D2-like receptors through the β/γ subunit, leading to 
inactivation of the L/N calcium channels and activation 
of the G protein-coupled inwardly rectifying potassium 
channels (GIRK) (Yan et al., 1997; Lavine et al., 2002).
Other G protein-independent signaling routes of do-
pamine receptors have also been elucidated (Beaulieu et 
al., 2015) (Fig. 1). The dopamine receptors are able to 
interact directly with L/N type Ca2+ channels and iono-
tropic channels such as glutamate and GABA receptors, 
thus modulating their functions (Zamponi & Currie, 
2013; Li et al., 2014). In addition, molecules responsible 
for receptor phosphorylation and desensitization, such as 
GRKs and β-arrestins, may mediate the dopamine func-
tions through the G protein-independent pathways of 
dopamine receptors (Tiberi et al., 1996; Kim et al., 2001; 
Del’Guidice et al., 2011; Peterson et al., 2015). The in-
volvement of dopamine receptors through β-arrestin in 
the regulation of signaling pathways of several kinases, 
e.g. protein kinase B (Akt) and glycogen synthase ki-
nase 3 (GSK-3), has been reported. The D2R/β-arrestin 
2 interaction is followed by binding of Akt with protein 
phosphatase 2, causing Akt inactivation (Del’Guidice et 
al., 2011; Beaulieu et al., 2015). Since GSK-3 is inhibited 
by Akt, its inactivation implicates up-regulation of this 
pathway (Urs et al., 2012; Beaulieu et al., 2015).
It should also be mentioned that the signaling of do-
pamine receptors can be regulated through the modula-
tion of G protein activity. There is a group of proteins 
that act as regulators of signal transduction of GPCRs 
(Taymans et al., 2003; Anderson et al., 2010).
FUNCTIONAL DOPAMINE RECEPTOR OLIGOMERS WITH 
OTHER GPCRS
The regulation of intracellular signaling by GPCRs is 
multi-faceted and sophisticated. There is a large body of 
evidence that collaboration between GPCRs may alter 
the function of these receptors (Agnati et al., 2003; Beau-
lieu & Gainetdinov, 2005; Prinster et al., 2005; Milligan, 
2013; Perrault et al., 2014; Beaulieu et al., 2015). The for-
mation of receptor dimers, both homodimers and het-
erodimers, has been associated with significant changes 
in cell functions. For example, the homodimerization of 
D2R may induce allosteric modulation of the signaling 
of those receptors (Han et al., 2009). The formation of 
heterodimers by dopamine receptors has widely been re-
ported (Table 1). Moreover, direct interactions between 
D1 and D2 receptors have been observed (Lee at al., 
2004; Dziedzicka-Wasylewska et al., 2006; Łukasiewicz et 
al., 2009). Even though the influence of this dimer on 
PLC-mediated signaling is not satisfactorily studied, its 
significance in the regulation of diverse mental disor-
ders, such as schizophrenia, attention-deficit hyperactiv-
ity disorder, and addiction has been shown (Perreault et 
al., 2014a). Interactions between D1R and D3R (Zeng 
et al., 2004; Marcellino et al., 2008) have also been re-
ported. The D1R/D3R dimer formation results in an ad-
ditive vasorelaxant effect in rat mesenteric artery, caused 
by the stimulation of K+ channels. In addition, the in-
tramembrane D1R/D3R interaction potentiated D1R-
mediated behavioral effects in mice stimulated with D3R 
agonists. In turn, the D2R/D5R dimer formation has 
been demonstrated in HEK transfected cells (O’Dowd et 
al., 2013). This heterodimer attenuates extensive calcium 
mobilization stimulated by D3 agonists (So et al., 2009). 
Furthermore, co-localization between D2-like receptors, 
such as D2R/D3R (Scarselli et al., 2001; Pou et al., 2012) 
and D2R/D4R (Borroto-Escuela et al., 2011; Gonzalez et 
al., 2012a;) has also been established.
A high number of heterodimers of dopamine recep-
tors with other GPCRs causing changes in the func-
tions of separate receptors have been reported (Table 1). 
In this context, the D1R and D2R can interact with 
adenosine receptors (A1R and A2R) and form D1R-A1R 
(Gines et al., 2000; Toda et al., 2003) and D2R-A2R di-
mers (Canals et al., 2003; Borroto-Escuela et al., 2016). 
The formation of these heteromers causes changes in G 
protein signaling of dopamine receptors associated with 
the AC/PKA pathway, especially after co-activation with 
agonists. Heterodimers of adrenergic receptor subtypes 
α1B (α1BR) and β1 (β1R) with D4R have also been pro-
posed, demonstrating regulation of melanin synthesis 
and release in rat pineal gland (Gonzalez et al., 2012b). 
The formation of these heteromers results in inhibition 
of adrenergic receptor signaling by dopamine alongside 
with blocking serotonin and melatonin synthesis induced 
by adrenergic receptor ligands. Furthermore, the arrange-
ment of several dimers of angiotensin II receptor types 
1 and 2 (AT1R and AT2R, respectively) and dopamine 
receptors has been shown. The AT1 receptor formed 
heterodimers with D1R in immortalized renal proximal 
tubule cells from Wistar-Kyoto rats and spontaneous 
hypertensive rats (Zeng et al., 2005b). In the first case, 
angiotensin II regulated positively the D1R expression 
but no effect was observed in the cells from hyperten-
sive rats. In turn, formation of a D2R-AT1R heterodimer 
was observed in co-transfected HEK-293T cells, show-
ing that this interaction did not affect the D2R-induced 
cAMP signaling but could attenuate AT1R coupling to 
Gq (Martinez-Pinilla et al., 2015). The D3R receptor co-
localizes with AT1R in immortalized renal proximal tu-
bule cells from rats leading to decreased AT1R expres-
sion by D3R agonist (Zeng et al., 2006). On the other 
hand, the D5R-AT1R formation can negatively regulate 
the expression of any other receptor by agonists (Zeng 
et al., 2005a). The second angiotensin receptor, AT2R, 
can interact with D1R and cooperatively increase the 
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cAMP and cGTP production with Ca2+ transport in-
hibition (Gildea et al., 2012). Additionally, a crosstalk 
between D2R and a cannabinoid receptor (CB1R) has 
been reported, demonstrating physical interactions be-
tween these receptors (Kearn et al., 2005). Co-activation 
of D2R-CB1R results in initiation of a cAMP-dependent 
signaling cascade distinct from those of the participant 
receptors, with changes in neurotransmission. Another 
heterodimer of dopamine receptors with GPCRs is in-
volved in the interaction of D3R with endothelin recep-
tor type B (ETBR). The formation of this dimer was 
observed in renal proximal tubule cells of Wistar-Kyoto 
and hypertensive rats, showing significant importance 
for hypertension regulation (Yu et al., 2009). A differ-
ent heterodimer established, generated from D2R and 
galanin receptor 1 (Gal1R), modulates cholinergic neuro-
transmission in the rat ventral hippocampus (Moreno et 
al., 2011a). Other GPCRs that are able to dimerize with 
dopamine receptors are histamine H3 receptors. The 
D1R-H3R dimer formation induces a different crosstalk 
of the participating receptors, which is associated with 
protein conformational changes upon activation of the 
partner receptor causing subsequent changes in recep-
tor signaling (Ferrada et al., 2009; Moreno et al., 2011b). 
In turn, the generation of the D2R-H3R dimer causes 
an H3R agonist-mediated diminution of D2R affinity 
for the agonist (Ferrada et al., 2008). The interaction of 
the N-methyl-d-aspartate receptor (NMDAR) with D1R 
(Lee et al., 2002; Nai et al., 2010) and D2R (Liu et al., 
2006) has also been documented. The carboxyl tail of 
the D1 receptor can directly and selectively interact with 
NMDA glutamate receptor subunits and the formation 
of the dimer results in inhibition or attenuation of the 
NMDA receptor-mediated excitotoxicity depending on 
subunit interaction. In turn, a direct and dynamic D2R-
NR2B subunit interaction in striatal neurons reduces the 
NMDAR signaling. Moreover, a heterocomplex involving 
D2R, NMDAR, and metabotropic glutamate receptor 5 
has recently been proposed as an intermediate complex 
(Borroto-Escuela et al., 2016). Another heterodimer that 
regulates cellular signaling is formed between D2R and 
neurotensin receptor type 1 (NTS1R) (Borroto-Escuela et 
al., 2016). NTS1R agonists induce D2 inhibition of the 
AC–PKA–CREB pathway. Physical interactions between 
D2R and the serotonin 5HT2A receptor (5HT2AR) have 
been reported (Borroto-Escuela et al., 2010; Łukasiewicz 
et al., 2010). Serotonin, the endogenous ligand of 
5-HT2A, exerts an allosteric antagonistic action on D2R 
signaling in the 5-HT2A–D2R complex. In contrast, hal-
lucinogenic agonists lead to potentiation of Gi/o sign-
aling of the D2R, producing an enhanced inhibition of 
the AC–PKA pathway in these heteroreceptor complex-
es (Borroto-Escuela et al., 2016). Although so far there 
have been no studies on the coupling of the serotonin 
5HT2A receptor with D1R, a D1R-mediated effect on 
pyramidal neuron plasticity induced by agonists of sero-
tonin receptor has been reported (Meunier et al., 2015). 
The established interaction between D2R and somatosta-
Table 1. Heterodimers of dopamine receptors and their functional relevance.
Dimer Changes in cell signaling or receptor functions References
D1R-D2R
D1R-D3R
D2R-D3R
D2R-D4R
D2R-D5R
D1R-A1R
D2R-A2AR
D4R-α1BR
D4R-β1R
D1R-AT1R
D2R-AT1R
D3R- AT1R
D5R- AT1R
D1R-AT2R
D2R-CB1R
D3-ETBR
D1R-Gal1R
D1R-H3R
D2R-H3R
D1R-NMDAR
D2R-NMDAR
D2R-NST1R
D2R-5HT2AR
D2R-SST5R
D2R-TAAR1
Co-activation induces enhanced Ca2+ release; GSK-3β inactivation
Vasorelaxant effect in rat mesenteric artery; D3 agonists potentiate D1-media-
ted mice locomotor activity
D2R receptor rescues the ability of D3R to inhibit AC-VI
D2R potentiates D4R-mediated inhibition of glutamate release
Attenuation of Ca2+ signaling mediated by D5R
Co-activation decreases the D1R-induced accumulation of cAMP and leads to 
uncoupling of D1R from G protein
A2AR agonists inhibit D2R Gαi/0-mediated signaling and D2R β-arrestin-mediated 
signaling
Dopamine inhibits adrenergic receptor signaling
Dopamine inhibits adrenergic receptor signaling
AT1R agonist regulates positively the D1R expression
Allosteric interaction between the heteromers a G protein complex
D3R agonist regulates AT1R expression
Activation of D5 and AT1 receptors negatively regulates the expression of each 
other
Increased cAMP and cGMP production, Na+ transport inhibition
Potentiation of AC inhibition after co-stimulation
D3 agonist enhances ETBR expression by a calcium channel-mediated mecha-
nism
Modulation of the cholinergic neurotransmission in hippocampus
Receptor antagonists lead to conformational changes in each receptor with 
blocking of original dimer signaling
H3R agonists decrease the D2R affinity for specific agonists
D1R agonist regulates NMDAR-mediated functions by a PI3K-dependent mecha-
nism
Disruption of the association of Ca2+/calmodulin-dependent protein kinase II 
with the NR2B subunit with reduction of NMDAR signaling
NST1R agonists inhibit the D2R-mediated AC/PKA pathway
5HT2AR activation by an endogenous agonist attenuates the D2R-dependent 
AC/PKA pathway release
SST5R agonist and D2R agonist enhance the inhibition of cAMP release
D2R agonists enhance the TAAR1-mediated cAMP release
Lee et al., 2004; Perrault et al., 
2014
Zeng et al., 2004; Marcellino et al., 
2008
Scarcelli et al., 2001
Gonzalez et al., 2012a
So et al., 2009
Gines et al., 2000; Toda et al., 2003
Borroto-Escuela et al., 2016
Gonzalez et al., 2012b
Gonzalez et al., 2012b
Zheng et al., 2005b
Martinez-Pinilla et al., 2015
Zeng et al., 2006
Zeng et al., 2005a
Gildea et al., 2012
Kearn et al., 2005
Yu et al., 2009
Moreno et al., 2011a
Ferrada et al., 2009; Moreno et al., 
2011b
Ferrada et al., 2008
Lee et al., 2002; Nai et al., 2010
Liu et al., 2006
Borroto-Escuela et al., 2016
Borroto-Escuela et al., 2010
Rocheville et al., 2000
Espinoza et al., 2011
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tin receptor subtype 5 (SST5R) enhances the functional 
activity of SSTR5R after dopamine stimulation or the 
D2R-mediated AC inhibition by SST5R agonists (Roche-
ville et al., 2000). Other cooperation of dopamine re-
ceptors includes the interaction between D2R and trace 
amine associated receptor 1 (TAAR1) that is crucial for 
the modulation of the dopaminergic system by TAAR1 
(Espinoza et al., 2011; Leo et al., 2014).
Significant implications for the modulation of cell 
signaling through a majority of these complexes have 
been described. However, the possibility that dopamine 
receptors may interact with other GPCRs forming new 
dimers is feasible. For example, kinin receptors, which 
are widely spread in tissues and responsible for numer-
ous physiological functions, may be regarded as potential 
partners for a crosstalk with dopamine receptors. Here-
under we describe their structural and functional charac-
teristics in order to find convergence of signaling path-
ways.
KININ RECEPTORS – CHARACTERISTICS AND 
SIGNALING
Another group of G protein-coupled receptors, on 
which the current review is focused, includes kinin re-
ceptors. Kinins are well known pro-inflammatory pep-
tides dynamically produced and degraded under physi-
ological conditions at the vessel wall and at sites of local 
infection or injury (Joseph & Kaplan, 2005; Guevara-
Lora et al., 2011; Guevara-Lora et al., 2013). The most 
important representatives of this group are bradykinin 
and kallidin (Lys-bradykinin), which can be specifically 
degraded by carboxypeptidases to form des-Arg-kinins 
– des-Arg9-bradykinin (DABK) and des-Arg10-kallidin 
(DAKD), respectively. These peptides, although modi-
fied, retain their biological activity (Blais et al., 2000; 
Leeb-Lunderg et al., 2005). Kinins have protective effects 
on the circulatory system, determining its homeostasis, 
and on the electrolyte and glucose transport, but there 
is also evidence for the participation of these peptides 
and their metabolites in different disorders associated 
with chronic inflammatory responses such as those as-
sociated with cardiovascular and renal diseases, diabetes, 
cancer, chronic pain, and neurodegeneration (Marceau et 
al., 2002; Leeb-Lunderg et al., 2005; Moreau et al., 2005; 
Figueroa et al., 2012; Guevara-Lora, 2012). Kinins and 
their metabolites without the C-terminal arginine residue 
are recognized by two types of receptors, the bradykinin 
receptor type 1 (B1R) and type 2 (B2R). B1R preferably 
binds des-Arg peptides, while B2R primarily recognizes 
bradykinin and kallidin. B2R is ubiquitously present on 
numerous cells, while the B1R expression in cell mem-
branes is mainly induced by certain stimuli.
Kinin receptors act through the G proteins, activating 
similar pathways (Fig. 2). The main G protein subtype 
involved in their signaling is Gαq, which initiates a signal 
transduction cascade through phospholipase C (PLC), 
leading to IP3 hydrolysis and DAG generation. Further 
reactions imply an increase in intracellular Ca2+ and PKC 
activation (Blaukat, 2003; Leeb-Lundberg et al., 2005; 
Marceau et al., 2013). Nitric oxide synthase induction 
with subsequent nitric oxide production is stimulated via 
Gαq through Ca2+-dependent mechanisms in endothe-
lial cells. Prostaglandin release is also mediated by Ca2+, 
which activates cytosolic phospholipase A2. In turn, 
Figure 2. Signaling of kinin receptors. 
The activation of several cellular processes is mediated by B1R and B2R through different G protein subunits and the β-arrestin protein. 
The outline of the signaling of kinin receptors was prepared on the basis of the information contained in articles cited in the text. AC, 
adenylate cyclase; Akt, protein kinase B; AP-1, activator protein 1; B1R, bradykinin receptor type 1; B2R, bradykinin receptor type 2; BK, 
bradykinin; DABK, des-Arg9-bradykinin; DAG, diacylglycerol; DAKD, des-Arg10-kallidin; IP3, inositol triphosphate; KD, kallidin; MAPK, mito-
gen-activated protein kinases; MEK, MAPK kinase; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells; PI3K, phospho-
inositide 3 kinase; PGI2, prostacyclin I2; PKA, protein kinase A; PKC, protein kinase C; PLC, phospholipase C.
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DAG recruits PKC, promoting tyrosine phosphorylation 
in mitogen-activated protein kinases (MAPK). Another 
signaling by bradykinin is associated with phospholipase 
D activation, which is mediated by Ca2+ influx and PKC.
Besides the Gαq subunit, kinin receptors may also 
transmit a signal through other G proteins. The B1R 
coupling to Gαq and Gαi was demonstrated by immu-
noprecipitation (Austin et al., 1997). Additional B2R in-
teractions with the Gβγ and Gαi subunits, activating 
PLC, have been observed (Camps et al., 1992; Philip et 
al., 2007). An interaction between B2R and the Gαq and 
Gβγ subunits, which mediates the activation of several 
transcription factors such as NF-kB and AP-1 by brady-
kinin through PI3K/Akt pathways, has been suggested 
(Xie et al., 2000; Zhu et al., 2003). Since both kinin re-
ceptors are involved in similar signaling pathways, their 
desensitization with subsequent internalization could be 
the critical factor in inferring the contribution of these 
receptors (Prado et al., 2002; Leeb-Lunderg et al., 2005). 
B2R is constitutively expressed in cell membrane but 
after kinin stimulation can desensitize with subsequent 
internalization and resensitization. The phosphorylation 
of the B2R C-terminal domain is necessary for receptor 
densensitization and internalization. The desensitization 
is regulated through interactions of the phosphorylated 
receptor with β-arrestin (Marceau et al., 2013). B1R can-
not internalize completely in response to agonists, partly 
because of the absence of phosphorylation sites in the 
C-terminal domain. The slow and extended cellular re-
sponse of this receptor is attributed to its inability to in-
ternalize (Enquist et al., 2014). Therefore, the divergence 
between B1R and B2R signaling is associated with de-
sensitization mechanisms.
FUNCTIONAL RELEVANCE OF KININ RECEPTOR 
COUPLING
As in the case of other GPCRs, kinin receptors can 
also interact with other proteins directly in membranes. 
Besides interactions with proteins involved in kinin gen-
eration, such as some membrane enzymes, interactions 
of these receptors with other GPCRs comprising ho-
modimers and heterodimers have been proven (Table 2). 
So far, the most extensively studied area encompasses 
homodimerization of B1R and B2R. The first report 
showing B2R dimerization with attenuated receptor-me-
diated signalization was published at the end of the nine-
ties (AbdAlla et al., 1999). The report provided evidence 
for a significant role of the N-terminal domain of B2R 
for the agonist-induced receptor dimerization. Further-
more, post-translation modifications such as N-glycosyla-
tion, sialylation, and disulphide bonding seem to be cru-
cial for B2R dimerization (Michineau et al., 2006). B1R 
can also occur in membranes in the homodimer form. 
Physical interactions between these receptors, substantial 
for their adequate functions, have been reported (Kang 
et al., 2005). Recently, it has been shown that the forma-
tion of B1R dimers may already take place at the stage 
of protein translation and maturation (Sanden & Leeb-
Lundberg, 2013). The authors proved that the dimeriza-
tion was required for the trafficking of the B1 receptor. 
In addition, it was shown that some fragments of trans-
membrane helices 1, 2, 3, and 4 seemed to be of vital 
importance for the interaction.
At the same time, the interest in the studies on the 
formation of heterodimers by kinin receptors has been 
growing. The heterologous B1R-B2R interaction was 
demonstrated for the first time in membranes of pros-
tate cancer PC3 cells (Barki-Harrington et al., 2003). In 
this report, it was demonstrated that the antagonist of 
one of the receptors interferes with the signaling ability 
of the other, through Gαq mediation. It was suggested 
that the dimer may control the proliferation of cancer 
cells through PLCβ signaling. In addition, cells co-ex-
pressed with B1R and B2R showed spontaneous heter-
odimerization, which promoted hydrolytic degradation of 
B2R (Kang et al., 2004). The authors suggested that this 
proteolytic plasma membrane mechanism is necessary to 
remove B2R since this receptor quickly recycles and may 
be down-regulated after prolonged agonist stimulation. 
Therefore, this effect can partially explain the sustained 
signalization of B1 receptors during uncontrolled inflam-
matory response. Moreover, a recent report also sug-
gests that dimerization between B1R and B2R can be a 
regulating factor for the prolonged expression of B1R in 
membranes (Enquist et al., 2014). In addition, a more re-
cent report suggested down-regulation of B1R responses 
by the B2R agonist that is associated with co-endocytosis 
of the B1R-B2R dimer (Zhang et al., 2015). The sugges-
tions that B1R-B2R interactions may be involved in the 
regulation of receptor expression mediated by the ago-
nist of the partner receptor agree with previous reports, 
indicating autoregulation between B1R and B2R (Phagoo 
et al., 1999; Guevara-Lora et al., 2009).
The first report concerning the heterodimerization of 
the kinin receptor with other GPCRs appeared already 
at the beginning of this century. The dimerization of the 
angiotensin II type 1 receptor (AT1R) with B2R, with 
alteration of receptor sequestration was established (Ab-
dAlla et al., 2000). In that study, enhanced angiotensin 
signaling through Gα without a bradykinin effect was 
interpreted in terms of dimer formation. Moreover, the 
physical interaction between these receptors was also 
confirmed by confocal FRET imaging (Quitterer et al., 
2011). It was suggested that the mechanisms of coupled 
receptor endocytosis significantly differ from those of 
Table 2. Dimerization of kinin receptors and their documented functional relevance.
Dimer Changes in cell signaling or receptor functions References
B1R-B1R
B1R-B2R
B2R-B2R
B2R-AT1R
B2R-AT2R
B1R-apelin receptor
Receptor trafficking and maturation; essential for the presentation of the 
receptor in the membrane
Regulation of PLCβ activation; B2R proteolysis by B1R stimulation with ago-
nist; regulation of B1R expression on membrane by B2R agonist
Regulation of receptor internalization; receptor-mediated signal attenuation
AT1R-stimulated increase in G protein activation 
Enhanced production of NO and cGMP
Co-stimulation enhances activity of PKC signaling pathways, increases Ca2+ 
release and promotes eNOS phosphorylation,
Kang et al., 2005; Sanden & 
Leeb-Lundberg, 2013
Barki-Harrington et al., 2003; 
Kang et al., 2004; Enquist et al., 
2014; Zhang et al., 2015
AbdAlla et al., 1999
AbdAlla et al., 2000
Abadir et al., 2006
Bai et al., 2014
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monomers. Functional implications of the B2R-AT1R 
dimerization related to their contribution to angiotensin 
II hyperresponsiveness of mesangial cells were also ob-
served in an experimental model of hypertension (Ab-
dAlla et al., 2005). A second, functional dimer of B2R 
with angiotensin II type 2 receptor in PC12V cell mem-
branes was reported (Abadir et al., 2006). The physical 
interaction between these receptors initiates changes in 
intracellular phosphoprotein signaling activities enhanc-
ing production of NO and cGMP. A recent study has 
shown the formation of a B1R dimer with an apelin 
receptor involved in homeostasis regulation (Bai et al., 
2014). The interaction between these receptors leads to 
enhanced eNOS phosphorylation and PKC signaling 
pathways, increasing NO and Ca2+ release.
As described above, the phenomenon of dimerization 
occurs in a majority of GPCRs, including the subclasses 
of kinin and dopaminergic receptors. Therefore, it would 
be valuable to check out possible interactions between 
these receptors, which could indicate changes in their 
functions.
CONVERGENCE OF SIGNALING PATHWAYS OF KININ 
AND DOPAMINE RECEPTORS
The fact that kinin and dopamine receptors, due to 
their nature, act mainly through G proteins implies pos-
sible competition between receptors for the binding to 
these proteins. As mentioned above, the main subclasses 
of G proteins for dopaminergic receptors are Gαs, Gαi, 
and Gαo which transmit signals through the cAMP path-
ways (Fig. 1). On the other hand, B1R- and B2R-me-
diated alteration in cAMP may occur (Fig. 2) (Zhang et 
al., 2009; Ben-Shmuel et al., 2013). Several indirect path-
ways, including those activated by Gαs and Gαi subunits 
have been proposed. Therefore, simultaneous stimulation 
of kinin and dopamine receptors may alter cAMP sign-
aling pathways. Indeed, a crosstalk between dopaminer-
gic receptors and B1R has been demonstrated (De Brito 
Gariepy et al., 2010). A significant contribution of the 
D2 receptor in the antihypertensive effect of B1R an-
tagonists has recently been reported, suggesting that up-
regulated brain B1R could contribute to the regulation 
of arterial hypertension through the dopamine system.
The Gαq subunit seems to be a good partner for me-
diation of interactions between kinin and dopaminergic 
receptors, which may induce effective cross-talking be-
tween these receptors. Both kinin receptors and D1-like 
receptors transduce signals through this pathway with the 
activation of PLCβ, leading to increased release of calci-
um ions and DAG production. Recently, enhanced B1R 
expression in rat vascular smooth muscle cells induced 
by angiotensin II has been demonstrated. This effect, 
which was attributed to activation of MAPK pathways, 
was mediated by an AT1 receptor and an endothelin type 
A receptor (ETAR) (Morand-Contant et al., 2010). Since 
direct interactions between dopamine receptors D1, D2, 
D3 and D5, and AT1 have been described with signifi-
cant changes in receptor function or signaling (Table 1), 
it can therefore be suggested that B1R and dopaminergic 
receptors may interact through the regulation of process-
es associated with MAPK pathways.
Potential regulation of the B2R function by the D2-
like receptor can also be proposed. The first receptor 
acts through Gαq and activates PCLβ, whereas this path-
way is activated by the D2-like receptor through the Gβγ 
subunit. The activated PLCβ induces Ca2+ release, which 
mediates NO production, modulating several processes, 
such as vasodilatation or vasoconstriction (Leeb-Lunberg 
et al., 2005). Hence, the interaction between these recep-
tors could be responsible for the appearance of effects 
related to Ca2+-mediated functions. Indeed, in a study 
performed on neuroblastoma cell line SH-SY5Y, an in-
teraction of B2R with dopamine receptors was proposed 
(Hong et al., 2004). Haloperidol, an agonist of dopamine 
receptors, inhibits the intracellular Ca2+ release induced 
synergistically by bradykinin and neurosteroids or by 
bradykinin and sigma receptor agonists. In that report, 
the formation of oligomeric patterns involving GPCRs 
was suggested. Recently, a NO-mediated antidepressant 
effect of aripiprazole, a specific D2R agonist, has been 
demonstrated (Shafaroodi et al., 2015). Therefore, despite 
the fact that there is no direct evidence of the forma-
tion of heterodimers composed of B2R and dopamine 
receptors, the observations described above allow us to 
propose their existence.
A probable regulation of the functions of kinin and 
dopamine receptors through β-arrestin seems to be inter-
esting if one considers the importance of these proteins 
in the trafficking and maintenance of receptors in mem-
branes. The β-arrestin-mediated signaling of dopaminer-
gic receptors involves the Akt/GSK-3 pathway. Kinin 
receptors are also able to activate Akt signalization but 
through both Gαq and Gβγ (Leeb-Lundberg et al., 2005). 
It has even been demonstrated that the tyrosine kinase 
Akt mediates the cardioprotective impact of bradykinin 
during preconditioned ischemia but a clear evidence of 
β-arrestin participation in this effect has not been pre-
sented (Sharma et al., 2015). To date, the cooperation of 
β-arrestin with kinin receptors seems to be associated 
with protein internalization and receptor desensitization 
but not with direct signaling. Nevertheless, it cannot be 
excluded that signaling changes may be the result of re-
ceptor dimerization, which causes disturbances in its in-
ternalization.
An emerging trend in the understanding of the func-
tions of GPCRs is associated with its oligomerization, 
even hetero-oligomerization. The facts summarized 
above, concerning similar signaling of dopamine and 
kinin receptors, indicate that assembling of these pro-
teins in cellular membrane may occur and that such reor-
ganization could result in changes in signal transduction 
or even in agonist binding. Recently, there is increasing 
interest in research that relates to the allosteric modula-
tion of dimerized GPCRs, including kinin and dopamine 
receptors (Sharma, 2014; Beaulieu et al., 2015). These 
observations provide further evidence that a crosstalk 
between kinin and dopamine receptors is possible and 
can be useful in the regulation of many cellular process-
es. Generally, numerous cellular processes are mediated 
by kinin or dopamine receptors. Their activation regu-
lates a variety of physiological functions whose distur-
bance leads to systemic pathologies. In addition, ample 
evidence suggests that the interference in the signaling of 
the dopaminergic receptors and kinin receptors may oc-
cur. Therefore, the participation of kinin and dopamine 
receptors in the regulation of common processes argues 
in favor of mutual cooperation.
SUMMARY
On the basis of the reports summarized hereby, con-
cerning similar signaling of kinin and dopamine recep-
tors, the hypothesis of cooperation between them seems 
to be possible. Further studies focused on the elucida-
tion which element of this cooperation can be related to 
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the cross-talk of signaling pathways of independent re-
ceptors or to the direct interactions between receptors 
should be performed. The kinin and dopamine receptors 
are widely co-expressed in tissues, regulating often the 
same processes. In recent years, the researchers’ interest 
in GPCRs has rapidly increased because these transmem-
brane receptors possess a common signal transduction 
system and act as controllers of diverse physiological 
processes. Therefore, these proteins represent important 
targets for the development of new drug candidates with 
potential therapeutic applications.
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